ASTH EBITDA Growth
Astrana Health Inc · EBITDA Growth
ASTH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported69.89%period ending
ASTH TTM EBITDA YoY % (18.39% → 69.89%)
Year-over-year change
High-resolution chart · PNG
ASTH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 69.8947% | |
| 26.2904% | |
| -4.6242% | |
| -22.0722% | |
| -21.0303% | |
| -3.3627% | |
| 14.6763% | |
| 7.1481% | |
| 7.6476% | |
| 15.6675% | |
| 10.3588% | |
| 66.0186% | |
| 343.7893% | |
| 18.3872% |